CASI Pharmaceuticals Inc

NASDAQ:CASI

1.59

-0.06 (-3.64%)

Market Cap (Intraday)	215.53M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$5.1 Million
Adjusted EPS	-$0.05

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

CASI Pharmaceuticals Inc Stock, NASDAQ:CASI

9620 Medical Center Drive, Suite 300, Rockville, Maryland 20850

United States of America

Phone: +1.240.864.2600

Number of Employees: 144

http://www.casipharmaceuticals.com

Description

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.